← Back to Clinical Trials
Recruiting NCT07170202

NCT07170202 The Increasing Mindfulness Engagement Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07170202
Status Recruiting
Phase
Sponsor Florida State University
Condition Healthy Participants
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-09-30
Primary Completion 2027-07-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 29 Years
Study Type INTERVENTIONAL
Interventions
Mindfulness Smartphone Application

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-09-30 with a primary completion date of 2027-07-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to examine the feasibility and acceptability of different types of text messages and a integrated gaming app to increase engagement in a mindfulness mobile health application. 1. Does receiving text messages increase engagement in a mindfulness app? 2. Does an integrated gaming app increase engagement in a mindfulness app? Researchers will examine whether participants engage more in a mindfulness mobile health application if they receive text messages and if they engage in additional gaming app on their smartphone. Participants will: 1. Use a mindfulness and gaming mobile health application for 28-days. 2. Complete a pre-study survey, post-study survey, follow-up interview, and 3-month follow-up survey in addition to daily brief surveys.

Eligibility Criteria

Inclusion Criteria: 18-29 years old First-generation college student Undergraduate college student Living in the United States Meet criteria for binge drinking (5 drinks in about 2 hours) or heavy drinking (more than 14 drinks per week).

Contact & Investigator

Central Contact

Laura Reid Marks, PhD

✉ laura.reidmarks@med.fsu.edu

📞 (850)644-2334

Principal Investigator

Laura Reid Marks, PhD

PRINCIPAL INVESTIGATOR

Florida State University

Frequently Asked Questions

Who can join the NCT07170202 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 29 Years, studying Healthy Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07170202 currently recruiting?

Yes, NCT07170202 is actively recruiting participants. Contact the research team at laura.reidmarks@med.fsu.edu for enrollment information.

Where is the NCT07170202 trial being conducted?

This trial is being conducted at Tallahassee, United States.

Who is sponsoring the NCT07170202 clinical trial?

NCT07170202 is sponsored by Florida State University. The principal investigator is Laura Reid Marks, PhD at Florida State University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology